Healthcare & PharmaceuticalsBenefits of AstraZeneca COVID-19 shot outweigh risks as review continues - WHO

Reuters
1 minute read

AstraZeneca logo is reflected in a drop on a syringe needle in this illustration photo taken March 16, 2021. REUTERS/Dado Ruvic/Illustration

A World Health Organization (WHO) vaccine safety panel said on Wednesday that it considers that the benefits of the AstraZeneca (AZN.L) COVID-19 vaccine outweigh its risks and recommends that vaccinations continue.

"The WHO Global Advisory Committee on Vaccine Safety is carefully assessing the latest available safety data for the AstraZeneca vaccine. Once that review is completed, WHO will immediately communicate the findings to the public," it said in a statement a day after experts held a closed-door meeting.

Our Standards: The Thomson Reuters Trust Principles.